Dr. Thomas Lewis discusses atopic disorders, sublingual immunotherapy, and barrier function.
Thomas Lewis, DVM, DACVD, discusses atopic disorders, sublingual immunotherapy, and barrier function.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Zenrelia™ (ilunocitinib tablets): An Innovative, Once Daily Canine Treatment That Targets Itch
June 25th 2025Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help improve owner compliance and can be cost effective* for pet owners
Read More